REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Cutia Therapeutics (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Cutia Therapeutics Profile Updated: November 01, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Cutia Therapeutics is a company located in Hong Kong. It was incorporated on May 10, 2004, with a registered capital of 5 million yuan. The company's main products and services are not mentioned in the source. The customers and main markets are also not mentioned.

Headquarters
20/F, Huanzhi Building, 436 Heng Feng Road, Jingan District
Shanghai; Shanghai;

Contact Details: Purchase the Cutia Therapeutics report to view the information.

Website: http://www.cutiatx.com

Basic Information
Total Employees:
Purchase the Cutia Therapeutics report to view the information.
Outstanding Shares:
Purchase the Cutia Therapeutics report to view the information.
Registered Capital:
Purchase the Cutia Therapeutics report to view the information.
Financial Auditors:
Purchase the Cutia Therapeutics report to view the information.
Incorporation Date:
May 15, 2019
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
28.44%
Purchase this report to view the information.
21.39%
Purchase this report to view the information.
13.16%
Purchase this report to view the information.
11.28%
Purchase this report to view the information.
7.48%
Subsidiaries
Cutia Therapeutics (Hk) Limited (Hong Kong SAR, China)
100%
Company Performance
Financial values in the chart are available after Cutia Therapeutics report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
178.3%▲
Total operating revenue
132.96%▲
Operating profit (EBIT)
87.22%▲
EBITDA
-4.83%▼
Net Profit (Loss) for the Period
87.75%▲
Total assets
-15.71%▼
Total equity
-26.48%▼
Operating Profit Margin (ROS)
4677.67%▲
Net Profit Margin
4566.11%▲
Return on Equity (ROE)
84.57%▲
Debt to Equity Ratio
14.91%▲
Quick Ratio
-6.29%▼
Cash Ratio
-4.12%▼

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
Nanjing Pharmaceutical Company Limited
Chongqing Zhifei Biological Products Co.,Ltd.
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Jiangsu Gdk Biological Technology Co., Ltd
 
Shanghai Micurx Pharmaceutical Co., Ltd.
Mabwell (Shanghai) Bioscience Co., Ltd. (迈威(上海)生物科技股份有限公司)
 
Hangzhou Tianmushan Pharmaceutical Enterprise Co.,Ltd
Dizal (Jiangsu) Pharmaceutical Co., Ltd. (迪哲(江苏)医药股份有限公司)
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo